REQUEST A DEMO
Total
USD $0.00
Search more companies

ISU Abxis Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: ISU Abxis Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

ISU Abxis Co., Ltd. is a biopharmaceutical company based in Seongnam, South Korea. Founded in 2001, the company is a subsidiary of ISU Group and specializes in the development and manufacturing of therapeutic antibodies for the treatment of incurable diseases such as cancer and rare diseases. Their product portfolio includes Abciximab, Clotinab®, Abcertin®, and Fabagal®. In addition to their pharmaceutical products, ISU Abxis also operates in the diagnostic business division, providing diagnostic kits and reagents. The company is listed on the Korea Stock Exchange under the ticker symbol 086890.KR.

Headquarters
5F C-Dong 22 No.712 Daewangpangyo-Road, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;

Contact Details: Purchase the ISU Abxis Co.,Ltd. report to view the information.

Website: http://www.abxis.com

Basic Information
Total Employees:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Registered Capital:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the ISU Abxis Co.,Ltd. report to view the information.
Incorporation Date:
March 29, 2001
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
3.28%
Purchase this report to view the information.
0.16%
Purchase this report to view the information.
0.05%
Purchase this report to view the information.
0.02%
Purchase this report to view the information.
0.02%
Subsidiaries
(주)이수앱지스
Company Performance
Financial values in the chart are available after ISU Abxis Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
33.54%
Total operating revenue
33.52%
Operating profit (EBIT)
-258.45%
EBITDA
2007.2%
Net Profit (Loss) for the Period
-201.62%
Total assets
1.36%
Total equity
18.01%
Operating Profit Margin (ROS)
-19.03%
Net Profit Margin
-25.88%
Return on Equity (ROE)
-12.4%
Debt to Equity Ratio
-21.71%
Quick Ratio
0.08%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?